Cargando…
In Vivo Fluorescence Immunohistochemistry: Localization of Fluorescently Labeled Cetuximab in Squamous Cell Carcinomas
Anti-EGFR (epidermal growth factor receptor) antibody based treatment strategies have been successfully implemented in head and neck squamous cell carcinoma (HNSCC). Unfortunately, predicting an accurate and reliable therapeutic response remains a challenge on a per-patient basis. Although significa...
Autores principales: | de Boer, Esther, Warram, Jason M., Tucker, Matthew D., Hartman, Yolanda E., Moore, Lindsay S., de Jong, Johannes S., Chung, Thomas K., Korb, Melissa L., Zinn, Kurt R., van Dam, Gooitzen M., Rosenthal, Eben L., Brandwein-Gensler, Margaret S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894408/ https://www.ncbi.nlm.nih.gov/pubmed/26120042 http://dx.doi.org/10.1038/srep10169 |
Ejemplares similares
-
Photoimmunotherapy of residual disease after incomplete surgical resection in head and neck cancer models
por: Moore, Lindsay S., et al.
Publicado: (2016) -
Fluorescence imaging to localize head and neck squamous cell carcinoma for enhanced pathological assessment
por: Warram, Jason M, et al.
Publicado: (2016) -
Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers
por: Gao, Rebecca W., et al.
Publicado: (2018) -
Perspective review of what is needed for molecular-specific fluorescence-guided surgery
por: Pogue, Brian W., et al.
Publicado: (2018) -
Specimen mapping in head and neck cancer using fluorescence imaging
por: Teraphongphom, Nutte, et al.
Publicado: (2017)